Steven Zeichner's profile

Steven Zeichner

Principal Investigator

University of Virginia

I'm working on

8 months ago

Vaccines, Mucosal Immunity, Viral Pathogenesis, Synthetic Biology

About

Leads development of an ultra-low-cost killed whole-cell, genome-reduced bacterial vaccine platform. 9+ US/EU patents/applications and funded programs in HIV and livestock coronaviruses. Work spans immunology, virology, and synthetic biology.

Partnering listings

Learn more

University of Virginia

Recombinant killed whole cell genome-reduced bacterial vaccine for AIBV

This innovative vaccine platform utilizes killed whole cell bacterial vaccines (KWC/GRB) to express pathogen subunits for broad protection. It leverages gram-negative autotransporter expression for cost-effective, scalab...

TechnologyIn developmentUniversity

Steven Zeichner

Principal Investigator

University of Virginia

Work experience

University of Virginia

Principal Investigator

Top industry applications

Vaccine development

Expertise

ImmunologyInfectious DiseasesVirology

Last updated Jan 2026